{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:00:13Z","timestamp":1774418413981,"version":"3.50.1"},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,8,15]]},"DOI":"10.2169\/internalmedicine.2955-23","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T22:14:20Z","timestamp":1705097660000},"page":"2251-2258","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of Gastric Epithelial Tumors in &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-uninfected Individuals Undergoing a Medical Checkup"],"prefix":"10.2169","volume":"63","author":[{"given":"Eiko","family":"Okimoto","sequence":"first","affiliation":[{"name":"Health Center, Shimane Environment and Health Public Corporation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Adachi","sequence":"additional","affiliation":[{"name":"Health Center, Shimane Environment and Health Public Corporation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ebisutani","sequence":"additional","affiliation":[{"name":"Health Center, Shimane Environment and Health Public Corporation, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Ishimura","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Shimane University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with <i>Helicobacter pylori<\/i>. IARC Monogr Eval Carcinog Risks Hum 61: 177-240, 1994."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Uemura N, Okamoto S, Yamamoto S, et al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.","DOI":"10.1056\/NEJMoa001999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with <i>Helicobacter pylori<\/i> infection increases risk of gastric cancer. Int J Cancer 109: 138-143, 2004.","DOI":"10.1002\/ijc.11680"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kato S, Matsukura N, Tsukada K, et al. <i>Helicobacter pylori<\/i> infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci 98: 790-794, 2007.","DOI":"10.1111\/j.1349-7006.2007.00478.x"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of <i>Helicobacter pylori<\/i>-negative gastric cancer among Japanese. Helicobacter 16: 415-419, 2011.","DOI":"10.1111\/j.1523-5378.2011.00889.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. <i>Helicobacter pylori<\/i>-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc 27: 551-561, 2015.","DOI":"10.1111\/den.12471"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Yamada A, Kaise M, Inoshita N, et al. Characterization of <i>Helicobacter pylori<\/i>-na\u00efve early gastric cancers. Digestion 98: 127-134, 2018.","DOI":"10.1159\/000487795"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 34: 609-619, 2010.","DOI":"10.1097\/PAS.0b013e3181d94d53"},{"key":"9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0034-1364955","volume":"46","author":"H Ueyama","year":"2014","unstructured":"9. Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy 46: 153-157, 2014.","journal-title":"Endoscopy","ISSN":"https:\/\/id.crossref.org\/issn\/0013-726X","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Benedict MA, Lauwers GY, Jain D. Gastric adenocarcinoma of the fundic gland type: update and literature review. Am J Clin Pathol 149: 461-473, 2018.","DOI":"10.1093\/ajcp\/aqy019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ueyama H, Yao T, Akazawa Y, et al. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol 56: 814-828, 2021.","DOI":"10.1007\/s00535-021-01813-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Akazawa Y, Ueyama H, Hayashi T, et al. Clinicopathological and molecular characterization of early gastric adenocarcinoma in <i>Helicobacter pylori<\/i>-uninfected patients: emphasis on differentiated gastric adenocarcinoma. J Gastroenterol 57: 725-734, 2022.","DOI":"10.1007\/s00535-022-01906-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yoshii S, Hayashi Y, Takehara T. <i>Helicobacter pylori<\/i>-negative early gastric adenocarcinoma with complete intestinal mucus phenotype mimicking verrucous gastritis. Dig Endosc 29: 235-236, 2017.","DOI":"10.1111\/den.12782"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shibagaki K, Itawaki A, Miyaoka Y, et al. Intestinal-type gastric dysplasia in <i>Helicobacter pylori<\/i>-na\u00efve patients. Virchows Arch 480: 783-792, 2022.","DOI":"10.1007\/s00428-021-03237-9"},{"key":"15","unstructured":"15. Nakazawa K, Yoshinaga S, Okuda N, et al. Endoscopic characteristics of adenoma of gastric phenotype (pyloric gland adenoma). I To Cho (Stomach and Intestine) 55: 1036-1042, 2020 (in Japanese)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Isono Y, Baba Y, Mukai K, et al. Gastric adenocarcinoma coexisting with a reddish semipedunculated polyp arising from <i>Helicobacter pylori<\/i>-negative normal gastric mucosa: a report of two cases. Clin J Gastroenterol 11: 481-486, 2018.","DOI":"10.1007\/s12328-018-0887-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shibagaki K, Fukuyama C, Mikami H, et al. Gastric foveolar-type adenomas endoscopically showing a raspberry-like appearance in the <i>Helicobacter pylori<\/i>-uninfected stomach. Endosc Int Open 7: E784-E791, 2019.","DOI":"10.1055\/a-0854-3818"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sakamoto U, Adachi K, Kishi K, et al. Prevalence of raspberry-type gastric foveolar-type tumor in individuals undergoing medical checkups. Intern Med 62: 2775-2781, 2023.","DOI":"10.2169\/internalmedicine.1265-22"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ishibashi F, Hirasawa T, Ueyama H, Minato Y, Suzuki S. Exploring quality indicators for the detection of <i>Helicobacter pylori<\/i>-na\u00efve gastric cancer: a cross-sectional nationwide survey. Clin Endosc 56: 460-469, 2023.","DOI":"10.5946\/ce.2022.167"},{"key":"20","unstructured":"20. Sekine S, Montgomery E, Vieth M. Foveolar-type adenoma. In: WHO Classification of Digestive System Tumours. 5th ed. 2019: 79-80."},{"key":"21","unstructured":"21. Kushima R. Introduction of &quot;gastric-type neoplasia in the stomach and duodenum&quot; . I To Cho (Stomach and Intestine) 57: 1495-1498, 2022 (in Japanese)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Adachi K, Kishi K, Notsu T, et al. Serum anti-<i>Helicobacter pylori<\/i> IgG antibody titer in <i>H. pylori<\/i>-negative cases with a different gastric mucosal atrophy status. Intern Med 59: 2817-2823, 2020.","DOI":"10.2169\/internalmedicine.5132-20"},{"key":"23","unstructured":"23. Aoyama N, Shigeta S, Yokozaki H. Evaluation of 6 H. pylori antibody serological diagnosis kits using the same samples strictly diagnosed the status of <i>H. pylori<\/i> infection. Nihon Helicobacter Gakkaishi (Jpn J Helicobacter Res) 21: 112-120, 2020 (in Japanese)."},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tokai Y, Fujisaki J, Ishizuka N, et al. Usefulness of the l-type Wako <i>Helicobacter pylori<\/i> antibody J test. JGH Open 5: 673-678, 2021.","DOI":"10.1002\/jgh3.12553"},{"key":"25","unstructured":"25. Haruma K, Ed. Kyoto Classification of Gastritis. Nihon Medical Center, Tokyo, 2017."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Watanabe K, Nagata N, Nakashima R, et al. Predictive findings for <i>Helicobacter pylori<\/i>-uninfected, -infected and -eradicated gastric mucosa: validation study. World J Gastroenterol 19: 4374-4379, 2013.","DOI":"10.3748\/wjg.v19.i27.4374"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kato M, Terao S, Adachi K, et al. Changes in endoscopic findings of gastritis after cure of <i>H. pylori<\/i> infection: multicenter prospective trial. Dig Endosc 25: 264-273, 2013.","DOI":"10.1111\/j.1443-1661.2012.01385.x"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1: 87-97, 1969.","DOI":"10.1055\/s-0028-1098086"},{"key":"29","unstructured":"29. Yoshida Y, Kurahara K, Yaita H, et al. Clinicopathological characteristics of <i>Helicobacter pylori<\/i>-uninfected advanced gastric cancer. I To Cho (Stomach and Intestine) 55: 1061-1076, 2020 (in Japanese)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2955-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T03:29:15Z","timestamp":1723865355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/16\/63_2955-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2955-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"2955-23"}}